Celltrio
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $3M
Investors
- 1
About Celltrio
Celltrio is a US-based company that provides advanced automation solutions for cell maintenance and culture, enhancing laboratory efficiency through cutting-edge technology.Founded in 2018 and headquartered in Fremont, US, Celltrio specializes in automating cell maintenance and culture processes. It operates independently without known subsidiaries or parent companies.Celltrio specializes in providing advanced automation solutions for cell maintenance and culture, with a core offering centered around their RoboCell™ system. This system operates continuously to streamline processes including cell passage, differentiation, transformation, and biobanking, ensuring high-quality management of a diverse range of cell lines, including primary, immortalized, and induced pluripotent stem cells (iPSCs). The technology incorporates a user-friendly visual interface that allows clients to define, schedule, and monitor complex workflows in real time, providing crucial metrics on environmental conditions and inventory status. Celltrio's customer base includes research institutions, biotechnology companies, and pharmaceutical organizations, predominantly located in North America, Europe, and Asia.Celltrio's revenue model is structured around the sale and leasing of their RoboCell™ automation systems, complemented by subscription services for software updates and maintenance. Transactions typically occur directly between Celltrio and its clients, with agreements often encompassing long-term partnerships that include training, support, and consumable supplies necessary for cell culture operations. The pricing structure reflects the extensive capabilities of their flagship RoboCell™ system, which integrates multiple functions into a single platform, making it a pivotal investment for laboratories seeking to enhance their operational efficiency. Ongoing revenue is also generated through the provision of consumables and accessories essential for cell culture maintenance, fostering repeat business from established clients. This strategy includes launching new products designed to optimize laboratory automation and targeting specific markets in Europe and Asia for expansion.
Who invested in Celltrio
1 investor across 1 round
See all investors in Celltrio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2025
Amount
$3M
Investors
Questions about Celltrio
Who invested in Celltrio?
Celltrio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celltrio raised?
Celltrio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Celltrio last raise money?
Celltrio's most recent round on record is a Series A, in Jun 2025.
What does Celltrio do?
Celltrio is a US-based company that provides advanced automation solutions for cell maintenance and culture, enhancing laboratory efficiency through cutting-edge technology.
Where is Celltrio headquartered?
Celltrio is headquartered in Fremont, US.
Which VCs invest in companies like Celltrio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celltrio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Celltrio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.